Category Research Guides

ISLA-RT is an investigational incretin-class peptide with agonist activity across GLP-1, GIP and glucagon receptors. What multi-receptor agonism means.

GLP2-T is an investigational peptide studied at the GLP-2 receptor. What that receptor does, its unusual cellular location, and how it differs from GLP-1.

KLOW combines GHK-Cu, BPC-157, TB-500 and KPV in one vial. Components, the added NF-kappaB arm, and the interpretive limits of blends.

GLOW combines GHK-Cu, BPC-157 and TB-500 in one vial. What each component does, and why a blend is harder to interpret than a single compound.

CJC-1295 (no DAC) is a GHRH analogue; Ipamorelin is a selective ghrelin receptor agonist. Why the two are studied together and how the pathways differ.

MT-2 is a cyclic analogue of alpha-MSH acting as a non-selective melanocortin receptor agonist. Structure, receptor promiscuity and why selectivity matters.

KPV is the three-residue C-terminal fragment of alpha-MSH, studied for NF-kappaB-associated anti-inflammatory signalling without pigmentary effects.

NAD+ is a dinucleotide coenzyme central to redox reactions and consumed as a substrate by sirtuins and PARPs. Two distinct roles worth separating.

Glutathione is an endogenous tripeptide and the principal intracellular antioxidant. Structure, the GSH/GSSG redox couple, and why the gamma linkage matters.

IGF1-LR3 is an IGF-1 analogue modified to evade binding proteins, giving it far greater potency in culture. Structure, mechanism and why the modification matters.